HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xi Zhang Selected Research

FSC 231

11/2021FSC231 alleviates paclitaxel-induced neuralgia by inhibiting the interactions between PICK1 and GluA2 and activates GSK-3β and ERK1/2.
10/2021FSC231 can alleviate paclitaxel-induced neuralgia by inhibiting PICK1 and affecting related factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xi Zhang Research Topics

Disease

245Neoplasms (Cancer)
10/2022 - 12/2004
77Infections
12/2022 - 08/2003
45Inflammation (Inflammations)
10/2022 - 09/2004
40Breast Neoplasms (Breast Cancer)
06/2022 - 03/2010
37Leukemia
11/2022 - 04/2004
31Neoplasm Metastasis (Metastasis)
03/2022 - 01/2009
25Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2009
22Carcinogenesis
01/2022 - 11/2008
22Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 02/2009
19Pain (Aches)
03/2022 - 10/2011
16Hematologic Neoplasms (Hematological Malignancy)
11/2022 - 03/2008
15Wounds and Injuries (Trauma)
05/2022 - 04/2009
15Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 11/2013
14Multiple Myeloma
11/2022 - 06/2011
14Hypoxia (Hypoxemia)
08/2022 - 04/2011
14Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 04/2014
14Alzheimer Disease (Alzheimer's Disease)
10/2021 - 02/2009
13Disease Progression
08/2022 - 01/2011
13Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2022 - 03/2009
13Barrett Esophagus (Barrett's Esophagus)
01/2022 - 01/2007
13Carcinoma (Carcinomatosis)
01/2022 - 07/2007
13Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2021 - 04/2009
13Hepatocellular Carcinoma (Hepatoma)
01/2021 - 11/2008
11Lung Neoplasms (Lung Cancer)
10/2022 - 12/2004
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 04/2013
11Fibrosis (Cirrhosis)
08/2022 - 11/2007
11Stomach Neoplasms (Stomach Cancer)
06/2022 - 09/2010
11Drug Resistant Epilepsy
05/2022 - 01/2020
11Glioma (Gliomas)
05/2022 - 06/2015
11Ovarian Neoplasms (Ovarian Cancer)
12/2020 - 01/2009
10Prostatic Neoplasms (Prostate Cancer)
04/2022 - 06/2013
10Lymphoma (Lymphomas)
01/2022 - 03/2011
10Hypertension (High Blood Pressure)
01/2022 - 06/2010
10Gastroesophageal Reflux (GERD)
01/2022 - 07/2007
10Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 12/2012
10Type 2 Diabetes Mellitus (MODY)
11/2021 - 03/2010
10Cognitive Dysfunction
07/2021 - 01/2015
10Adenocarcinoma
07/2021 - 07/2007
9Neuralgia (Stump Neuralgia)
03/2022 - 03/2016
9Ischemia
03/2022 - 07/2010
9Residual Neoplasm
01/2022 - 04/2004
9Parkinson Disease (Parkinson's Disease)
01/2022 - 12/2011
9Trichinellosis
02/2020 - 12/2014
9Retinal Detachment (Retinal Detachments)
01/2016 - 05/2003
8COVID-19
10/2022 - 01/2020
8Fever (Fevers)
04/2022 - 12/2013
8Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 12/2014
8Autoimmune Diseases (Autoimmune Disease)
12/2021 - 06/2011
8Epilepsy (Aura)
08/2021 - 01/2018
8Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2014
8Brain Ischemia (Cerebral Ischemia)
01/2018 - 03/2009
7Cachexia
10/2022 - 01/2021
7Liver Neoplasms (Liver Cancer)
07/2022 - 09/2010

Drug/Important Bio-Agent (IBA)

85Proteins (Proteins, Gene)FDA Link
03/2022 - 03/2005
55Biomarkers (Surrogate Marker)IBA
10/2022 - 03/2012
39Pharmaceutical PreparationsIBA
06/2022 - 05/2007
36Messenger RNA (mRNA)IBA
12/2022 - 01/2008
25AntigensIBA
01/2022 - 07/2007
24Biological ProductsIBA
07/2022 - 12/2011
24MicroRNAs (MicroRNA)IBA
01/2022 - 01/2015
21VaccinesIBA
06/2022 - 03/2009
19Chimeric Antigen ReceptorsIBA
11/2022 - 01/2017
18Long Noncoding RNAIBA
09/2022 - 04/2014
18CytokinesIBA
08/2022 - 11/2009
18RNA (Ribonucleic Acid)IBA
04/2022 - 01/2017
17DNA (Deoxyribonucleic Acid)IBA
11/2022 - 07/2007
17Indicators and Reagents (Reagents)IBA
10/2022 - 12/2011
17Glucose (Dextrose)FDA LinkGeneric
10/2022 - 01/2010
17AcidsIBA
01/2022 - 01/2007
16Small Interfering RNA (siRNA)IBA
12/2022 - 01/2009
14AntibodiesIBA
02/2020 - 11/2007
13Therapeutic UsesIBA
01/2022 - 01/2005
12CollagenIBA
08/2022 - 07/2013
12Retinaldehyde (Retinal)IBA
06/2022 - 12/2002
12Phosphotransferases (Kinase)IBA
01/2022 - 03/2007
12Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2021 - 02/2009
11Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2011
10Peptides (Polypeptides)IBA
09/2022 - 09/2012
10AlbuminsIBA
06/2022 - 08/2017
10EnzymesIBA
11/2021 - 09/2008
10Anti-Bacterial Agents (Antibiotics)IBA
08/2021 - 08/2003
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 08/2008
9Bile Acids and Salts (Bile Acids)IBA
01/2022 - 02/2008
9Immunoglobulin G (IgG)IBA
01/2022 - 02/2014
9Histones (Histone)IBA
08/2021 - 01/2008
9Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021 - 04/2009
8CateninsIBA
12/2021 - 04/2016
7Hemoglobins (Hemoglobin)IBA
10/2022 - 01/2015
7C-Reactive ProteinIBA
10/2022 - 05/2014
7IntegrinsIBA
06/2022 - 12/2010
7LipidsIBA
06/2022 - 01/2010

Therapy/Procedure

124Therapeutics
11/2022 - 05/2007
50Drug Therapy (Chemotherapy)
11/2022 - 05/2010
42Hematopoietic Stem Cell Transplantation
12/2022 - 02/2009
19Transplantation
12/2022 - 02/2009
14Immunotherapy
01/2022 - 01/2020
13Stem Cell Transplantation
11/2022 - 01/2011
11Radiotherapy
03/2022 - 04/2013
10Vagus Nerve Stimulation
11/2021 - 01/2020
8Length of Stay
04/2022 - 01/2012